
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Discovery Platform
Sponsor : HDT Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
MalarVx licenses HDT Bio's repRNA/LION™ Technology for Novel Malaria Vaccine
Details : Under the license agreement, MalarVx grants HDT access to the epRNA and LION platforms to support malaria vaccine formulation.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
January 16, 2025
Lead Product(s) : Undisclosed
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Discovery Platform
Sponsor : HDT Biotech
Deal Size : Undisclosed
Deal Type : Licensing Agreement
